Drug intelligence / Profile preview

butylidenephthalide

Development stage
Preclinical
Modality
Small Molecules
01

Overview

Butylidenephthalide is a natural, low molecular weight, liposoluble gamma-lactone compound found in several plants including Angelica sinensis and Ligusticum chuanxiong. It is a bioactive phthalide derivative with multiple pharmacological activities. In traditional Chinese medicine, it has been used for treating anemia and gynecological dysfunction. Pharmacologically, butylidenephthalide exhibits anti-fibrotic effects in the liver by modulating TGF-beta/BMP7 signaling pathways and inhibiting epithelial–mesenchymal transition (EMT). It also demonstrates neuroprotective activity and can cross the blood–brain barrier to inhibit growth of glioblastoma multiforme tumors via induction of apoptosis through Nur77-mediated pathways, cell cycle arrest (via p16/p21), telomerase inhibition (hTERT repression), and regulation of mitochondrial/ER stress apoptotic pathways. Additionally, it shows cytotoxic or inhibitory effects on various cancers such as brain, lung, colon, prostate, liver cancers; has antiplatelet properties; and may protect against neurotoxicity by regulating tryptophan 2,3-dioxygenase[1][5][8][9].

Brand names
CerebracaCerebraca Wafer
Other names
Ligusticum lactoneButylidene phthalide3-butylidene-1(3H)-isobenzofuranonen-butylidene phthalideBdph3-butylidene-phthalid3-butylideneisobenzofuran-1(3H)-oneButenylphthalide
02

Targets

FASN (Fatty acid synthase)TERT (Telomerase)

Beyond the preview

Go deeper on butylidenephthalide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on butylidenephthalide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call